Form 4: DaVita Legal Chief's Routine Equity Transactions

DaVita's Chief Legal & Public Affairs Officer, Kathleen Alyce Waters, reported the acquisition of new equity awards and the disposal of shares to cover tax obligations from vested stock units.

Summary

• Kathleen Alyce Waters, DaVita Inc.'s Chief Legal & Public Affairs Officer, reported several equity transactions on March 15, 2026.
• Acquired 3,185 restricted stock units (RSUs) which are scheduled to vest 50% on March 15, 2029, and 50% on March 15, 2030.
• Disposed of a total of 33,863 shares of common stock at a price of $150.72 per share to satisfy tax withholding obligations.
• These disposals were related to the vesting of 4,829 performance stock units (PSUs) from the 2025 performance period, 51,330 PSUs from the 2023-2025 performance period, 1,989 RSUs (50%) granted in 2022, and 9,205 RSUs (50%) granted in 2023.
• Acquired 8,610 stock appreciation rights (SARs) with an exercise price of $150.72, scheduled to vest 50% on March 15, 2029, and 50% on March 15, 2030, and expire on March 15, 2031.
• Following these transactions, the reporting person beneficially owns 124,599 shares of common stock and 8,610 stock appreciation rights.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine executive compensation events and tax-related share disposals, which are expected and do not indicate significant positive or negative operational or financial developments for DaVita Inc.

Positives

• Acquisition of 3,185 restricted stock units (RSUs) and 8,610 stock appreciation rights (SARs) indicates continued long-term incentive alignment with company performance.
• The vesting of performance stock units (PSUs) and restricted stock units (RSUs) reflects the achievement of performance criteria and/or service periods.

Negatives

• The disposal of 33,863 shares of common stock to cover tax withholding obligations reduces the reporting person's direct equity ownership in the company.

Future Outlook

The filing indicates future vesting schedules for newly acquired restricted stock units and stock appreciation rights, with 50% vesting on March 15, 2029, and the remaining 50% on March 15, 2030. The stock appreciation rights are set to expire on March 15, 2031.

Industry Context

StockSavvy.ai notes that executive equity awards and subsequent tax-related share disposals are standard practices in public companies, aligning executive incentives with shareholder value over the long term. These transactions reflect routine compensation events rather than strategic shifts or market-moving news.

Comparison to Industry Standards

• StockSavvy.ai observes that the structure of equity compensation, including restricted stock units and stock appreciation rights with multi-year vesting schedules, is consistent with common practices among large-cap healthcare service providers.
• Companies like Fresenius Medical Care AG & Co. KGaA (FMS) and Baxter International Inc. (BAX) also utilize similar long-term incentive plans to retain and motivate key executives, linking compensation to future performance and share price appreciation.

Related Party Transactions

• The transactions involve the Chief Legal & Public Affairs Officer of DaVita Inc. acquiring and disposing of company equity, which are considered related party transactions under SEC rules for insider reporting.

Stakeholder Impact

• Shareholders: The transactions represent routine executive compensation and tax management, which are generally expected. The reduction in direct share ownership due to tax withholding is offset by new equity awards, maintaining executive alignment with long-term shareholder interests.
• Employees: No direct impact on general employees is indicated.
• Management: The transactions reflect the ongoing compensation structure for the Chief Legal & Public Affairs Officer, providing long-term incentives.

Next Steps

• 50% of the newly acquired restricted stock units and stock appreciation rights are scheduled to vest on March 15, 2029.
• The remaining 50% of the newly acquired restricted stock units and stock appreciation rights are scheduled to vest on March 15, 2030.
• The newly acquired stock appreciation rights will expire on March 15, 2031.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, including the vesting of equity awards and subsequent tax-related share disposals, along with the grant of new long-term incentives. These transactions are expected and do not provide new fundamental information that would warrant a change in investment thesis. Therefore, a seasoned investor would likely maintain their current position, hence a 'hold' recommendation.

Keywords

DaVita Inc., DVA, Form 4, Insider Trading, Stock Appreciation Rights, Restricted Stock Units, Performance Stock Units, Executive Compensation, Kathleen Alyce Waters, Equity Awards, Rule 10b5-1